3SBIO

www.taishunjiguang.com 提示:

本信息僅供醫學專業人士參考，如果您是醫學專業人士，請點擊確定后進入。如果不是，請點擊取消。

取消 確定

Our 3SBio

3SBIO 2020 Interim Results Announcement

revenue of approximately RMB 2.695 billion, up 2.0% year on year. Gross profit increased by 1.5% to approximately RMB 2.217 billion. Net profit attributable to owners of the parent soared 118.6% to RMB approximately 703 million.

Read the report online

Our science

Focusing on technology, innovation and internationalization is always the direction of our drug R&D

Cover the whole process of drug development, ranging from basic research, pre-clinical research, clinical trial to new drug registration and marketing.

Learn more

Our products

Meeting the demands of patients is the core of all actions

we have a wealth of product series under study, with nearly 30 kinds of listed products and 25 kinds of alternative products.

Learn more

Our responsibilities

Working together to make the world healthier

Always focus on high-quality drugs to improve the quality of life of patients for the benefit of human health.

Learn more

Fields we focus on

Latest news

Sunshine Guojian Selects Verseau’s VSIG4-targeted ...

Early data in patient-derived primary tumors suggest that VSIG4 antibodies could generate a greater ...

2020-12-14

Sunshine Guojian Selects Verseau’s VSIG4-targeted ...

Early data in patient-derived primary tumors suggest that VSIG4 antibodies could generate a greater ...

2020-12-14

3SBio Announces Acceptance of IND application for ...

Marketing authorization for SB8 was granted by the European Commission on Aug 19, 2020.

一本到高清视频不卡dvd,高清一本dvd,一本道av,日本一本二本三区无码

www.taishunjiguang.com 提示:

取消 確定

Cherish lifeCare for lifeCreate life

Our 3SBio

3SBIO 2020 Interim Results Announcement

revenue of approximately RMB 2.695 billion, up 2.0% year on year. Gross profit increased by 1.5% to approximately RMB 2.217 billion. Net profit attributable to owners of the parent soared 118.6% to RMB approximately 703 million.

Our science

Focusing on technology, innovation and internationalization is always the direction of our drug R&D

Cover the whole process of drug development, ranging from basic research, pre-clinical research, clinical trial to new drug registration and marketing.

Our products

Meeting the demands of patients is the core of all actions

we have a wealth of product series under study, with nearly 30 kinds of listed products and 25 kinds of alternative products.

Our responsibilities

Working together to make the world healthier

Always focus on high-quality drugs to improve the quality of life of patients for the benefit of human health.

Fields we focus on

Latest news

Sunshine Guojian Selects Verseau’s VSIG4-targeted ...

2020-12-14

Sunshine Guojian Selects Verseau’s VSIG4-targeted ...

2020-12-14

3SBio Announces Acceptance of IND application for ...

2020-09-14

一本到高清视频不卡dvd,高清一本dvd,一本道av,日本一本二本三区无码